Advertisement
Advertisement
U.S. Markets close in 6 hrs 4 mins
Advertisement
Advertisement
Advertisement
Advertisement

Femasys Inc. (FEMY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.6974-0.1726 (-3.54%)
As of 09:53AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.8700
Open4.9000
Bid4.4000 x 1000
Ask4.8500 x 1300
Day's Range4.6974 - 4.9000
52 Week Range3.7700 - 13.7500
Volume1,425
Avg. Volume81,408
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.50
  • GlobeNewswire

    Femasys Inc. Announces Financial Results for the Third Quarter of 2021

    -- Up to 792-patient, pivotal LOCAL trial progressing for FemaSeed® after receipt of investigational device exemption (IDE) submission approval -- -- Femasys added to the Russell Microcap® Index in Q3 -- ATLANTA, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced financial results for t

  • GlobeNewswire

    Femasys Inc. to Present at The MedTech Conference

    ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that Kathy Lee-Sepsick, chairman, president and chief executive officer, will participate in a presentation at The MedTech Conference. Ms. Lee-Sepsick will speak on a panel in a session, entitled, “Early-Stage Medtech and Goin

  • GlobeNewswire

    Femasys Inc. To Join the Russell Microcap® Index

    ATLANTA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (“Femasys” or the “Company”), a biomedical company developing a suite of product candidates to transform women’s healthcare with minimally invasive, non-surgical, in-office technologies, announced that the Company has been added to the Russell Microcap® Index today when the U.S. market opened. The Russell Microcap Index is widely used by investment managers and institutional investors for index funds and as benchmarks for ac

Advertisement
Advertisement